ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research
ICON plc (NASDAQ: ICLR), a leading healthcare intelligence and clinical research organisation, has received multiple prestigious awards in late 2024. The company ranked highest among clinical research organizations on TIME Magazine's 2024 World's Best Companies list and secured the 57th position on the 2025 World's Best Companies in Sustainable Growth list.
Notable achievements include winning the Scrip award for Best Contract Research Organisation for the fifth time in eight years, and the Best Practices Recognition award from the Frost and Sullivan Institute. Individual recognition went to executives Barry Balfe (PharmaVoice 100 List) and Rose Kidd (Businesswoman Award), while Alexander Murray was named IRT Young Professional 2024.
The company also excelled in creative and digital marketing, winning multiple awards including Health + Wellness awards, MarCom Awards, and Stevie® Awards for various clinical study materials and technological innovations.
ICON plc (NASDAQ: ICLR), un'organizzazione leader nell'intelligence sanitaria e nella ricerca clinica, ha ricevuto numerosi premi prestigiosi alla fine del 2024. L'azienda si è classificata al primo posto tra le organizzazioni di ricerca clinica nella lista delle 2024 World's Best Companies di TIME Magazine e ha ottenuto il 57° posto nella lista delle aziende più sostenibili per il 2025.
Tra i risultati notevoli spicca la vittoria del premio Scrip come Migliore Organizzazione di Ricerca Contrattuale per la quinta volta in otto anni e il premio di Riconoscimento delle Migliori Pratiche dal Frost and Sullivan Institute. Riconoscimenti individuali sono andati ai dirigenti Barry Balfe (PharmaVoice 100 List) e Rose Kidd (Businesswoman Award), mentre Alexander Murray è stato nominato IRT Young Professional 2024.
L'azienda ha ottenuto anche riconoscimenti nel marketing creativo e digitale, vincendo diversi premi tra cui Health + Wellness awards, MarCom Awards e Stevie® Awards per vari materiali di studio clinico e innovazioni tecnologiche.
ICON plc (NASDAQ: ICLR), una organización líder en inteligencia de salud e investigación clínica, ha recibido múltiples premios prestigiosos a finales de 2024. La compañía ocupó el primer lugar entre las organizaciones de investigación clínica en la lista de TIME Magazine de las Mejores Empresas del Mundo 2024 y aseguró la 57ª posición en la lista de las Mejores Empresas del Mundo en Crecimiento Sostenible 2025.
Logros notables incluyen ganar el premio Scrip como Mejor Organización de Investigación Contractual por quinta vez en ocho años, y el premio de Reconocimiento de Mejores Prácticas del Frost and Sullivan Institute. El reconocimiento individual fue otorgado a los ejecutivos Barry Balfe (PharmaVoice 100 List) y Rose Kidd (Businesswoman Award), mientras que Alexander Murray fue nombrado IRT Young Professional 2024.
La empresa también brilló en marketing creativo y digital, ganando múltiples premios que incluyen los Health + Wellness awards, MarCom Awards y Stevie® Awards por diversos materiales de estudio clínico e innovaciones tecnológicas.
ICON plc (NASDAQ: ICLR), 헬스케어 인텔리전스 및 임상 연구 분야의 선도적인 조직인 ICON plc는 2024년 말 여러 개의 권위 있는 상을 수상했습니다. 이 회사는 TIME 매거진의 2024년 세계 최고의 기업 목록에서 임상 연구 조직 중 가장 높은 순위를 차지했으며, 2025년 지속 가능한 성장 부문 세계 최고의 기업 목록에서 57번째로 선정되었습니다.
주요 성과로는 8년 중 5회 연속 2024년 최고 계약 연구 조직으로 스크립(Scrip)상을 수상한 것과 Frost and Sullivan Institute로부터의 모범 사례 인정상이 있습니다. 개인적인 인식은 Barry Balfe(PharmaVoice 100 목록)와 Rose Kidd(여성 경영인 상)에게 돌아갔으며, Alexander Murray는 2024년 IRT Young Professional로 선정되었습니다.
이 회사는 또한 창의적이고 디지털 마케팅 분야에서 두각을 나타내며, 다양한 임상 연구 자료와 기술 혁신으로 Health + Wellness Awards, MarCom Awards 및 Stevie® Awards 등 여러 상을 수상했습니다.
ICON plc (NASDAQ: ICLR), une organisation de recherche clinique et d'intelligence sanitaire de premier plan, a reçu plusieurs prix prestigieux à la fin de 2024. L'entreprise a été classée première parmi les organisations de recherche clinique dans la liste des Meilleures entreprises du monde 2024 de TIME Magazine et a sécurisé la 57ème position dans la liste des entreprises les plus durables en 2025.
Parmi les réalisations notables figure le gain du prix Scrip pour la meilleure organisation de recherche contractuelle pour la cinquième fois en huit ans, ainsi que le prix de reconnaissance des meilleures pratiques décerné par l'Institut Frost and Sullivan. Des distinctions individuelles ont été attribuées aux dirigeants Barry Balfe (PharmaVoice 100 Liste) et Rose Kidd (Businesswoman Award), tandis qu'Alexander Murray a été nommé IRT Young Professional 2024.
L'entreprise a également excellé dans le marketing créatif et numérique, remportant plusieurs prix, notamment des Health + Wellness awards, des MarCom Awards et des Stevie® Awards pour divers matériaux d'études cliniques et des innovations technologiques.
ICON plc (NASDAQ: ICLR), eine führende Organisation für Gesundheitsintelligenz und klinische Forschung, hat Ende 2024 mehrere angesehene Auszeichnungen erhalten. Das Unternehmen belegte den höchsten Rang unter den klinischen Forschungsorganisationen in der TIME Magazine-Liste der besten Unternehmen der Welt 2024 und sicherte sich den 57. Platz auf der Liste der besten Unternehmen für nachhaltiges Wachstum 2025.
Bemerkenswerte Erfolge sind der Gewinn des Scrip Awards für die beste Vertragsforschungsorganisation zum fünften Mal in acht Jahren und der Preis für beste Praktiken des Frost and Sullivan Institute. Einzelne Anerkennung erhielten die Führungskräfte Barry Balfe (PharmaVoice 100 Liste) und Rose Kidd (Businesswoman Award), während Alexander Murray als IRT Young Professional 2024 ausgezeichnet wurde.
Das Unternehmen excelierte auch im kreativen und digitalen Marketing und gewann mehrere Auszeichnungen, darunter Health + Wellness Awards, MarCom Awards und Stevie® Awards für verschiedene Materialien klinischer Studien und technologische Innovationen.
- None.
- None.
On TIME Magazine’s 2024 list of World’s Best Companies ICON was ranked as the highest clinical research organisation out of 1,000 companies for the second year in a row, and in its 2025 list of World’s Best Companies in Sustainable Growth it was featured at number 57 out of 500 companies. ICON was also announced as a winner of the Best Practices Recognition award from the Frost and Sullivan Institute’s Enlightened Growth Leadership awards.
ICON was also honoured with a 2024 Scrip award for Best Contract Research Organisation (Full Service Providers). These awards acknowledge the critical role of CROs in delivering specialist outsourced services for all aspects of clinical trials. This is the fifth time ICON has won this coveted industry award in the last eight years.
Two members of ICON’s executive leadership team were acknowledged for professional accomplishment. Barry Balfe was named to the 2024 PharmaVoice 100 List, which recognises the most inspiring leaders in life sciences. Rose Kidd was announced as the recipient of the Businesswoman Award at the 2024 Women Mean Business Awards in
ICON was also recognised across a range of creative and digital marketing awards. Its Creative & Digital Services and Patient Recruitment Services teams won two Health + Wellness awards from Graphic Design
ICON’s FIRECREST medical animation video, “The Invisible Machine,” won a gold MUSE award whilst at the 2024 Annual International Business Awards, ICON won two Stevie® Awards: Gold for a technology video showcasing AI platforms and wearables, and Bronze for the CARD system, which enhances clinical data distribution. At the 2024 Awards for Technical Excellence, ICON also won a Silver Stevie® for eClinical Development & Delivery’s tokenisation solution.
Steve Cutler, CEO, ICON commented: “It’s fantastic to end the year with recognition for both individual employees as well as ICON as a company. I’m incredibly proud of all the teams and individuals who were honoured in these awards, which demonstrate ICON’s commitment to delivering value and quality in the field of clinical research.”
A full list of ICON’s industry awards can be viewed at www.iconplc.com/awards.
About ICON plc
ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in
ICON/ICLR-G
View source version on businesswire.com: https://www.businesswire.com/news/home/20241223413171/en/
Claire Quinn, Corporate Communications, ICON
+353 87 4066091
claire.quinn@iconplc.com
Lisa Henry, Weber Shandwick (PR adviser)
+44 7785 458203
lhenry@webershandwick.com
Source: ICON plc
FAQ
What major rankings did ICON (ICLR) achieve in TIME Magazine's lists for 2024-2025?
How many times has ICON (ICLR) won the Scrip award for Best Contract Research Organisation?
Which ICON (ICLR) executives received individual recognition in 2024?
What creative and digital marketing awards did ICON (ICLR) win in 2024?
What technology-related awards did ICON (ICLR) receive in 2024?
